← Leaderboards
Vinit B Mahajan
Stanford University
$8,007,061
Attributed
$13,356,935
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,356,935 · 10
By mechanism
R01$11,756,470 · 7
K08$1,139,515 · 1
R21$430,950 · 1
R13$30,000 · 1
Top collaborators
- Alexander G Bassuk21 shared
- Stephen H Tsang11 shared
- Polly J Ferguson4 shared
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessEye DiseasesGenesPhenotypeAffectInheritedInflammationMolecularMutationUveitisBaseCellsRetinalRetinaIn VivoProteinsNeovascularPathway InteractionsMolecular GeneticsInflammatoryInnovationMutantCalciumIn Vitro
Grant awards (37)
Integrated Molecular Profiling of Diabetic Retinopathy$1,786,652
R01 · FY2025 · EY · contact PI
Inflammatory Gene Transcription in the Retina$396,171
R01 · FY2024 · EY · contact PI
Proteomic Biomarkers of Intraocular Infection$410,002
R01 · FY2023 · EY · contact PI
Inflammatory Gene Transcription in the Retina$396,098
R01 · FY2023 · EY · contact PI
Proteomic Biomarkers of Intraocular Infection$397,702
R01 · FY2022 · EY · contact PI
Inflammatory Gene Transcription in the Retina$383,245
R01 · FY2022 · EY · contact PI
FASEB SRC: The Biology of Calpains in Health and Disease$30,000
R13 · FY2022 · EY · contact PI
Proteomic Biomarkers of Intraocular Infection$397,702
R01 · FY2021 · EY · contact PI
Inflammatory Gene Transcription in the Retina$381,549
R01 · FY2021 · EY · contact PI
Proteomic Biomarkers of Intraocular Infection$410,002
R01 · FY2020 · EY · contact PI
Inflammatory Gene Transcription in the Retina$407,791
R01 · FY2020 · EY · contact PI
Structure and Function of Calpain-5$392,500
R01 · FY2019 · EY · contact PI
Mechanistic Studies on Regenerative Medicine Approaches to Childhood Blindness$389,825
R01 · FY2019 · EY
Gene Silencing and Gene Editing in Phototransduction$394,762
R01 · FY2018 · EY
Structure and Function of Calpain-5$392,500
R01 · FY2018 · EY · contact PI
Mechanistic Studies on Regenerative Medicine Approaches to Childhood Blindness$389,825
R01 · FY2018 · EY
Mechanism-based therapies for photoreceptor degeneration$357,285
R01 · FY2018 · EY · contact PI
Gene Silencing and Gene Editing in Phototransduction$394,762
R01 · FY2017 · EY
Mechanistic Studies on Regenerative Medicine Approaches to Childhood Blindness$389,825
R01 · FY2017 · EY
Structure and Function of Calpain-5$377,500
R01 · FY2017 · EY · contact PI
Mechanism-based therapies for photoreceptor degeneration$187,592
R01 · FY2017 · EY · contact PI
Mechanism-based therapies for photoreceptor degeneration$119,195
R01 · FY2017 · EY · contact PI
Mechanistic Studies on Regenerative Medicine Approaches to Childhood Blindness$402,348
R01 · FY2016 · EY
Gene Silencing and Gene Editing in Phototransduction$394,762
R01 · FY2016 · EY
Structure and Function of Calpain-5$377,500
R01 · FY2016 · EY · contact PI
Mechanism-based therapies for photoreceptor degeneration$326,267
R01 · FY2016 · EY · contact PI
Evaluating GWAS AMD Candidate Loci by Gene Editing in Human iPS Cells$145,591
R21 · FY2016 · AG · contact PI
Evaluating GWAS AMD Candidate Loci by Gene Editing in Human iPS Cells$51,236
R21 · FY2016 · AG · contact PI
Gene Silencing and Gene Editing in Phototransduction$408,714
R01 · FY2015 · EY
Structure and Function of Calpain-5$377,500
R01 · FY2015 · EY · contact PI
Mechanism-based therapies for photoreceptor degeneration$316,894
R01 · FY2015 · EY · contact PI
Evaluating GWAS AMD Candidate Loci by Gene Editing in Human iPS Cells$234,123
R21 · FY2015 · AG · contact PI
Molecular Genetics of Dominant Neovascular Inflammatory Vitreoretinopathy$227,903
K08 · FY2015 · EY · contact PI
Molecular Genetics of Dominant Neovascular Inflammatory Vitreoretinopathy$227,903
K08 · FY2014 · EY · contact PI
Molecular Genetics of Dominant Neovascular Inflammatory Vitreoretinopathy$227,903
K08 · FY2013 · EY · contact PI
Molecular Genetics of Dominant Neovascular Inflammatory Vitreoretinopathy$227,903
K08 · FY2012 · EY · contact PI
Molecular Genetics of Dominant Neovascular Inflammatory Vitreoretinopathy$227,903
K08 · FY2011 · EY · contact PI